• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔乙型肝炎疫苗:壳聚糖或葡聚糖为基础的给药系统,可在皮下初免后有效免疫 HBsAg。

Oral hepatitis B vaccine: chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous priming.

机构信息

Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, 3004-517, Portugal; Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde Azinhaga de Santa Comba Coimbra, 3000-548, Portugal.

Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, 3004-517, Portugal; Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde Azinhaga de Santa Comba Coimbra, 3000-548, Portugal.

出版信息

Int J Pharm. 2018 Jan 15;535(1-2):261-271. doi: 10.1016/j.ijpharm.2017.11.009. Epub 2017 Nov 11.

DOI:10.1016/j.ijpharm.2017.11.009
PMID:29133207
Abstract

The World Health Organization encourages "the development of oral formulations to simplify their transport, storage and administration in poor countries", and to "facilitate an effective immunization program to prevent sexually transmitted hepatitis B". Thus, two distinct and promising delivery systems were developed: recombinant hepatitis B surface antigen (HBsAg) encapsulated into alginate-coated chitosan particles (AlgChiPs) and into glucan particles (GPs) mainly composed of β-1,3-d-glucan. In vitro preliminary studies showed that both could be internalized by peripheral blood mononuclear cells and murine Peyer's patches, an imperative aspect regarding oral immunization. Chitosan particles (ChiPs) have shown interesting immunostimulating properties as mast cells activators. Vaccination studies reveal that three oral immunizations induced serum anti-HBsAg Immunoglobulin G (IgG) in 60 % of the animals and anti-HBsAg secretory IgA in faeces for both formulations. When subcutaneous (SC) priming was done, followed by two oral boosts, all mice were responder and much higher serum anti-HBsAg IgG titers were observed, besides mucosal protective immunity.

摘要

世界卫生组织鼓励“开发口服制剂,以简化在贫穷国家的运输、储存和管理”,并“促进有效的免疫规划,以预防性传播乙型肝炎”。因此,开发了两种截然不同且有前途的递药系统:将重组乙型肝炎表面抗原(HBsAg)包封入藻酸盐包被的壳聚糖颗粒(AlgChiPs)和主要由β-1,3-d-葡聚糖组成的葡聚糖颗粒(GPs)。体外初步研究表明,这两种颗粒都可以被外周血单核细胞和小鼠派尔氏斑内吞,这是口服免疫的一个重要方面。壳聚糖颗粒(ChiPs)已显示出作为肥大细胞激活剂的有趣的免疫刺激特性。疫苗接种研究表明,两种制剂的 3 次口服免疫均可使 60%的动物血清抗-HBsAg 免疫球蛋白 G(IgG)和粪便中抗-HBsAg 分泌型 IgA 产生应答。当进行皮下(SC)初免,然后进行两次口服加强时,所有小鼠均有应答,并且观察到更高的血清抗-HBsAg IgG 滴度,以及黏膜保护性免疫。

相似文献

1
Oral hepatitis B vaccine: chitosan or glucan based delivery systems for efficient HBsAg immunization following subcutaneous priming.口腔乙型肝炎疫苗:壳聚糖或葡聚糖为基础的给药系统,可在皮下初免后有效免疫 HBsAg。
Int J Pharm. 2018 Jan 15;535(1-2):261-271. doi: 10.1016/j.ijpharm.2017.11.009. Epub 2017 Nov 11.
2
Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.海藻酸盐包被的壳聚糖纳米颗粒是一种有效的乙肝表面抗原皮下佐剂。
Int Immunopharmacol. 2008 Dec 20;8(13-14):1773-80. doi: 10.1016/j.intimp.2008.08.013. Epub 2008 Sep 16.
3
Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.通过在藻酸盐包被的壳聚糖纳米颗粒中经鼻递送乙型肝炎表面抗原和共递送CpG寡脱氧核苷酸引发免疫反应。
Eur J Pharm Biopharm. 2008 Jun;69(2):405-16. doi: 10.1016/j.ejpb.2008.01.019. Epub 2008 Jan 31.
4
Chitosan:β-glucan particles as a new adjuvant for the hepatitis B antigen.壳聚糖:β-葡聚糖颗粒作为乙肝抗原的新型佐剂。
Eur J Pharm Biopharm. 2018 Oct;131:33-43. doi: 10.1016/j.ejpb.2018.07.018. Epub 2018 Jul 23.
5
Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.对包裹于海藻酸盐包被的壳聚糖纳米颗粒中的乙型肝炎抗原进行短期口服疫苗接种方案后免疫反应的评估。
Eur J Pharm Sci. 2007 Dec;32(4-5):278-90. doi: 10.1016/j.ejps.2007.08.005. Epub 2007 Aug 15.
6
Lipopolysaccharide derived alginate coated Hepatitis B antigen loaded chitosan nanoparticles for oral mucosal immunization.用于口腔黏膜免疫的脂多糖衍生藻酸盐包被的负载乙肝抗原的壳聚糖纳米颗粒
Int J Biol Macromol. 2020 Jul 1;154:466-476. doi: 10.1016/j.ijbiomac.2020.03.124. Epub 2020 Mar 16.
7
M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes.利用霍乱毒素 B 亚单位连接的双层囊泡实现 M 细胞靶向递送重组乙型肝炎表面抗原。
Int J Pharm. 2010 Jan 29;385(1-2):47-52. doi: 10.1016/j.ijpharm.2009.10.027. Epub 2009 Oct 14.
8
Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.新型佐剂鼻用疫苗的研发:与壳聚糖纳米颗粒结合的C48/80作为增强黏膜免疫的途径
Eur J Pharm Biopharm. 2015 Jun;93:149-64. doi: 10.1016/j.ejpb.2015.03.024. Epub 2015 Mar 26.
9
Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen-loaded modified liposomes.使用负载乙肝表面抗原的修饰脂质体经皮免疫诱导的全身和黏膜免疫反应。
Eur J Pharm Sci. 2008 Apr 23;33(4-5):424-33. doi: 10.1016/j.ejps.2008.01.015. Epub 2008 Feb 12.
10
Glucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity.葡聚糖颗粒是乙肝表面抗原的有力佐剂,有利于抗病毒免疫。
Mol Pharm. 2019 May 6;16(5):1971-1981. doi: 10.1021/acs.molpharmaceut.8b01322. Epub 2019 Apr 23.

引用本文的文献

1
Yeast-Derived Glucan Particles: Biocompatibility, Efficacy, and Immunomodulatory Potential as Adjuvants and Delivery Systems.酵母衍生的葡聚糖颗粒:作为佐剂和递送系统的生物相容性、功效及免疫调节潜力
Pharmaceutics. 2025 Aug 8;17(8):1032. doi: 10.3390/pharmaceutics17081032.
2
RBC-hitchhiking PLGA nanoparticles loading β-glucan as a delivery system to enhance and immune responses in mice.负载β-葡聚糖的红细胞搭载聚乳酸-羟基乙酸共聚物纳米颗粒作为递送系统以增强小鼠免疫反应
Front Vet Sci. 2024 Sep 16;11:1462518. doi: 10.3389/fvets.2024.1462518. eCollection 2024.
3
Gp85 protein encapsulated by alginate-chitosan composite microspheres induced strong immunogenicity against avian leukosis virus in chicken.
由海藻酸钠-壳聚糖复合微球包裹的Gp85蛋白在鸡体内诱导了针对禽白血病病毒的强烈免疫原性。
Front Vet Sci. 2024 May 22;11:1374923. doi: 10.3389/fvets.2024.1374923. eCollection 2024.
4
Current Progress and Challenges in the Study of Adjuvants for Oral Vaccines.口服疫苗佐剂的研究现状与挑战
BioDrugs. 2023 Mar;37(2):143-180. doi: 10.1007/s40259-022-00575-1. Epub 2023 Jan 6.
5
Chitosan, alginate, hyaluronic acid, gums, and β-glucan as potent adjuvants and vaccine delivery systems for viral threats including SARS-CoV-2: A review.壳聚糖、海藻酸盐、透明质酸、胶、β-葡聚糖作为 SARS-CoV-2 等病毒威胁的有效佐剂和疫苗传递系统:综述。
Int J Biol Macromol. 2021 Jul 1;182:1931-1940. doi: 10.1016/j.ijbiomac.2021.05.155. Epub 2021 May 25.
6
Mast Cell-Biomaterial Interactions and Tissue Repair.肥大细胞-生物材料相互作用与组织修复。
Tissue Eng Part B Rev. 2021 Dec;27(6):590-603. doi: 10.1089/ten.TEB.2020.0275. Epub 2021 Jan 21.
7
Chitosan Nanoparticles: Shedding Light on Immunotoxicity and Hemocompatibility.壳聚糖纳米颗粒:揭示免疫毒性和血液相容性
Front Bioeng Biotechnol. 2020 Feb 21;8:100. doi: 10.3389/fbioe.2020.00100. eCollection 2020.
8
Activity and Cell-Death Pathway in Induced by Sugiol: Vectorization Using Yeast Cell Wall Particles Obtained From .受诱导的活性和细胞死亡途径:利用酵母细胞壁颗粒载体化 注:由于原文中“Sugiol”一词并未给出中文译名,我将其保留为英文。
Front Cell Infect Microbiol. 2019 Jun 14;9:208. doi: 10.3389/fcimb.2019.00208. eCollection 2019.
9
Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials.β-葡聚糖:补充剂还是药物?从实验室到临床试验。
Molecules. 2019 Mar 30;24(7):1251. doi: 10.3390/molecules24071251.